Related Experiment Video
Updated: Mar 17, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Pretransplant mortality in children awaiting living donor liver transplantation: a prospective center-based study
Tri Hening Rahayatri1,2, Ni Made Sarastri Widyani3, Hanifah Oswari2,4
1Pediatric Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, Indonesia.
Insights
Children awaiting pediatric liver transplants face high mortality, mainly from sepsis and malnutrition. Donor scarcity prolongs waiting times, increasing risks for pediatric liver transplantation candidates in Indonesia.
Area of Science:
- Pediatric Hepatology
- Transplant Surgery
- Public Health
Background:
- High mortality rates among children awaiting liver transplantation are a global concern.
- Indonesia's sole pediatric living-donor liver transplantation (LDLT) center faces similar challenges.
- Understanding waiting list mortality is crucial for improving outcomes.
Purpose of the Study:
- To determine the mortality rate in children listed for LDLT.
- To analyze the time to death or transplantation.
- To identify the primary causes of death in pediatric LDLT candidates.
Main Methods:
- Prospective single-center cohort study from January 2023 to December 2024.
- Inclusion of all eligible children (age 0-18) listed for LDLT.
- Monitoring from listing until death, transplantation, loss to follow-up, or study end.
Main Results:
- 62 children were enrolled; 72.58% had biliary atresia.
- 70.97% experienced malnutrition; 35.48% had prior cytomegalovirus (CMV) infection.
- Median time to death was 87.5 days; 22 deaths occurred, primarily due to sepsis.
Conclusions:
- Pediatric liver transplant candidates face significant waiting list mortality.
- Infection, malnutrition, and socioeconomic factors are key contributors.
- Sepsis remains the leading cause of death, highlighting the need for improved management and donor availability.
Background:
High mortality in children awaiting liver transplantation is a significant concern. At Cipto Mangunkusumo Hospital, the only active and established pediatric living-donor liver transplantation (LDLT) center in Indonesia, similar challenges persist. This study aims to determine the mortality rate, time to death or transplantation and causes of death in children listed for LDLT at our center.
Methods:
This prospective single-center cohort study was conducted from January 2023 to December 2024. Consecutive sampling included all eligible children age 0-18 listed for LDLT. Participants were monitored from listing until pretransplant death, transplantation, loss to follow-up or study completion. The primary outcome was all-cause mortality on the LDLT waiting list.
Results:
Sixty-two children were enrolled; 64.51% (n=40) were female with biliary atresia accounting for 72.58% of diagnoses. Malnutrition was identified in 70.97% (n=44) and 35.48% (n=22) had a history of cytomegalovirus (CMV) infection. Median duration from listing to death was 87.5 days. Median time to transplantation was 263.5 days. During follow-up, 22 children died with sepsis as the leading cause, 22 underwent LDLT, 13 were lost to follow-up and 5 remained on the waiting list. Donor scarcity contributed substantially to prolonged listing and loss to follow-up.
Conclusions:
Children listed for liver transplantation experience a high waiting list mortality at our center. This is primarily due to infection, malnutrition and socioeconomic factors. Sepsis persists as the principal cause of death. LDLT remains the only feasible option for children requiring liver transplantation in Indonesia.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

